Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426

被引：0
|
作者：
Naoki, K. [1 ]
Ichikawa, Y. [2 ]
Bessho, A. [3 ]
Hosokawa, S. [3 ]
Shimokawa, T. [4 ]
Yomota, M. [5 ]
Hosomi, Y. [5 ]
Otani, S. [1 ]
Nakahara, Y. [1 ]
Iwasawa, S. [6 ]
Tokito, T. [7 ]
Seki, N. [2 ]
Okamoto, H. [8 ]
机构：
[1] Kitasato Univ, Sch Med, Resp Med, Sagamihara, Kanagawa, Japan
[2] Teikyo Univ, Div Med Oncol, Dept Internal Med, Sch Med, Tokyo, Japan
[3] Japanese Red Cross Okayama Hosp, Resp Med, Okayama, Japan
[4] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[6] Chiba Univ, Chiba, Japan
[7] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
[8] Thorac Oncol Res Grp, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; performance status; nab-Paclitaxel;
D O I：
10.1016/j.jtho.2019.08.730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-15
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [1] Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: T0RG1426
    Ichikawa, Yasuko
    Seki, Nobuhiko
    Hosokawa, Shinobu
    Bessho, Akihiro
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    Otani, Sakiko
    Nakahara, Yoshiro
    Yomota, Makiko
    Hosomi, Yukio
    Murase, Kyoko
    Kishi, Kazuma
    Iwasawa, Shunichiro
    Nishimura, Takashi
    Kasai, Takashi
    Nakamura, Yoichi
    Watanabe, Koshiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1081 - S1081
  • [2] Multicenter, single-arm phase II study of modified carboplatin/ nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426
    Ichikawa, Yasuko
    Seki, Nobuhiko
    Honda, Takeshi
    Sakugawa, Makoto
    Hosokawa, Shinobu
    Bessho, Akihiro
    Agemi, Yoko
    Shimokawa, Tsuneo
    Otani, Sakiko
    Nakahara, Yoshiro
    Naoki, Katsuhiko
    Yomota, Makiko
    Hosomi, Yukio
    Takiguchi, Yuichi
    Tokito, Takaaki
    Ando, Shuji
    Okamoto, Hiroaki
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (04) : 873 - 886
  • [3] Camrelizumab combined with anlotinib and nab-paclitaxel in patients with untreated advanced mucosal melanoma: A single-arm, multicenter, exploratory study.
    Wu, Di
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients with Locally Advanced NSCLC
    Kawano, Y.
    Sasaki, T.
    Yamaguchi, H.
    Hirano, K.
    Nishio, M.
    Satouchi, M.
    Hosokawa, S.
    Morinaga, R.
    Komiya, K.
    Inoue, K.
    Fujita, Y.
    Toyozawa, R.
    Kimura, T.
    Takahashi, K.
    Nishikawa, K.
    Kishimoto, J.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S635 - S635
  • [5] A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease
    Usui, Y.
    Kenmotsu, H.
    Mori, K.
    Ono, A.
    Yoh, K.
    Baba, T.
    Fujiwara, Y.
    Yamaguchi, O.
    Ko, R.
    Okamoto, H.
    Yamamoto, N.
    Ninomiya, T.
    Ogura, T.
    Kato, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2
    Gajra, Ajeet
    Ali, Haythem
    Amiri, Katayoun I.
    Karim, Nagla A.
    Matrana, Marc R.
    Mulford, Deborah
    Ong, Teng J.
    Sanford, Alexandra
    Santos, Edgardo S.
    Socinski, Mark A.
    Spigel, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S274 - S274
  • [7] Phase I/II Study of Carboplatin, nab-paclitaxel, and Concurrent Radiation Therapy for Patients with Locally Advanced NSCLC
    Kawano, Y.
    Yamaguchi, H.
    Hirano, K.
    Horiike, A.
    Satouchi, M.
    Hosokawa, S.
    Morinaga, R.
    Komiya, K.
    Inoue, K.
    Fujita, Y.
    Takenoyama, M.
    Kimura, T.
    Okuno, M.
    Hisamatsu, Y.
    Kishimoto, J.
    Sasaki, T.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2014 - S2015
  • [8] Nab-paclitaxel maintenance therapy following carboplatin plus nab-paclitaxel combination therapy in chemotherapy naive patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Nakao, Akira
    Uchino, Junji
    Igata, Fumiyasu
    On, Rintaro
    Ikeda, Takato
    Yatsugi, Hiroshi
    Hirano, Ryosuke
    Sasaki, Tomoya
    Tanimura, Keiko
    Imabayashi, Tatsuya
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Nagata, Nobuhiko
    Watanabe, Kentaro
    Kishimoto, Junji
    Takayama, Koichi
    Fujita, Masaki
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 903 - 910
  • [9] Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Akira Nakao
    Junji Uchino
    Fumiyasu Igata
    Rintaro On
    Takato Ikeda
    Hiroshi Yatsugi
    Ryosuke Hirano
    Tomoya Sasaki
    Keiko Tanimura
    Tatsuya Imabayashi
    Nobuyo Tamiya
    Yoshiko Kaneko
    Tadaaki Yamada
    Nobuhiko Nagata
    Kentaro Watanabe
    Junji Kishimoto
    Koichi Takayama
    Masaki Fujita
    Investigational New Drugs, 2018, 36 : 903 - 910
  • [10] Gemcitabine plus nab-paclitaxel for second-line therapy of pancreatic cancer: A phase II, single-arm, multicenter study
    Huh, Gunn
    Choi, Jin Ho
    Lee, Sang Hyub
    Chun, Jung Won
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Hee Seung
    Bang, Seungmin
    ANNALS OF ONCOLOGY, 2021, 32 : S287 - S287
12345